Showing posts with label clinical trials. Show all posts
Showing posts with label clinical trials. Show all posts
Tuesday, November 16, 2010
Pathfinder Therapeutics update
Pathfinder Therapeutics, the Nashville-based VU spinoff that focuses on open and minimally invasive surgery using image-guided technologies, announced Sloan-Kettering and other universities are participating in clinical trials. The release is here. Related stories here.
Wednesday, October 14, 2009
BioMimetic trial results in
BioMimetic Therapeutics Inc. announced yesterday impressive data from randomized trials of its Augment Bone Graft product, showing it performed well in comparison with material harvested via autograft. The release is here. At 4:20 p.m. CT today, the stock was up about 20 percent over day-earlier.
Labels:
BioMimetic Therapeutics,
clinical trials,
FDA
Subscribe to:
Posts (Atom)